Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

Universal Biosensors

Status: Completed

Conditions: Clotting Disorders

Study type: Observational

Funder types: Industry

Identifiers

NCT01375725

MOB 0046

Details and patient eligibility

About

The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Are currently taking coumadin (warfarin)
• Are aged 18 years or older
• Able and willing to provide informed consent
• Can understand (read and write) English
• Required to provide a capillary sample as part of their routine medical check

Exclusion criteria

• Previously participated in this study

Trial design

60 participants in 1 patient group

Coumadin (warfarin)

Description:

Subjects currently receiving coumadin (warfarin) treatment.